NCT04023877View on ClinicalTrials.gov

A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

October 11, 2019

Study Completion Date

October 11, 2019

Conditions
Dementias With Lewy Bodies
Interventions
DRUG

E2027

E2027 oral capsule.

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT04023877 - A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants | Biotech Hunter | Biotech Hunter